DaVita Inc. (DVA)

NYSEHealthcare

$147.53
-$0.59 (-0.4%)
Market closed

April 17, 2026 at 16:00 UTC

Interactive Chart

DVA

12:29:02 UTC

About DaVita Inc.

Name
DaVita Inc.
CEO
Javier J. Rodriguez
Industry
Healthcare
Year Founded
1994
Employees
76,000

DaVita Inc. provides kidney care focused on patients living with chronic kidney disease and end-stage renal disease. The company operates outpatient centers, supports home therapies, and coordinates with nephrologists, hospitals, and payers to deliver ongoing treatment and education. Clinical teams handle dialysis delivery, access monitoring, and patient training, while care management programs address nutrition, medication, and follow-up. Digital tools help track treatments and connect patients with support outside the clinic. DaVita works across the United States and select international markets, aligning service models with local regulations and provider networks. Positioned within the healthcare sector, the company’s role sits at the intersection of chronic care delivery, coordinated benefits, and community-based services.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 6 Buy, 10 Hold, 7 Sell
Buy6
Hold10
Sell7

Fundamentals & Financials

Revenue (TTM)
$13.6B
Net Income (TTM)
$746.8M
EPS (TTM)
$9.27
ROA (TTM)
4.27%
Current Ratio
1.29
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$3,619.7M
Cost of Sales$2,596.2M
Gross Profit$1,023.5M
Operating Income$551,205K
Net Income$234,217K
EPS$2.51

Technical Indicators

DaVita Inc.'s Technical Indicators Summary

DVA presents a neutral technical stance with short and medium moving averages under pressure while longer‑term averages remain supportive, producing a mixed moving average picture. Momentum indicators are centered or mildly negative—RSI near neutral and MACD slightly negative—ADX shows limited trend strength and ATR denotes moderate volatility, while OBV is negative indicating net outflow. The price sits near the classic pivot. Technical takeaway: short‑term softness versus longer‑term support yields a neutral chart with no clear directional conviction.

Buy
6 signals
Neutral
10 signals
Sell
7 signals
Overall: Neutral43% Neutral signals
IndicatorValue
RSI (14)
47.86
Stochastic %K (14, 3, 3)
28.79
CCI (20)
-85.41
WPR (14)
-60.55
Momentum (10)
2.33
MFI
50.48
MACD Level (12, 26)
-0.11
Bollinger Bands
$144.53 - $156.84
ATR (14)
$4.04 (2.73%)
ADX (14)
18.88
OBV
-5,424,245
Classic Pivot Point
$147.31
Fibonacci Pivot Point
$147.31
Simple Moving Averages
$132.35 - $150.68(5 indicators)
Exponential Moving Averages
$137.84 - $149.54(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day wrapped with DVA just under water versus yesterday, after a tiny -0.15% gap and a close near 147.91. End-of-day, the peer group was modestly in the green at 1.48%, providing a small boost to sentiment. DVA slipped in a quiet session as a modestly higher peer group lent only a slim sentiment boost.

Price Change

from $147.53 close

+$0.32

Trading Volume

Below avg (666.9K)

499.1K

vs S&P 500 Today

Underperforming Market

-1.40%

52-Week Position

Upper range

80.3%

Updated: April 17, 2026 at 20:10 UTC

Quote Summary

OpenPrevious Close
$147.49$147.53
Day Range52 Week Range
$146.6 - $149.49$101 - $159.42
VolumeAvg. Volume
499.1K1M
Market CapP/E Ratio
$9.8B15.6